You are here

A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil

Last updated on December 5, 2018

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Erectile Dysfunction
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-80 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Male patients aged ≥ 18 years.

- Clinical diagnosis of erectile dysfunction supported by a total score of less than or
equal to 21 according to Sexual Health Inventory-Male (SHI-M).

- Patients having a sexual partner throughout the study.

- Patients having been switched to sildenafil after a previous treatment with udenafil
proved ineffective and/or was poorly tolerated. The evaluation of udenafil
ineffectivness should be performed after attempt intercourse 2 times a week over the
course of four weeks.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- The patients for whom sildenafil is contraindicated according to the Local Product
Document (LPD). (See appendix D)

- The patients for whom sexual activity is not indicated.

NCT01108900
Pfizer
Completed
A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your zip code, city, or country to find studies near you.

Similar Trials

Erectile Disfunction, Hemodialysis
NCT00654017
Males
19+
Years
Multiple Sites
Physiological Sexual Dysfunction
NCT00443027
Females
18+
Years
Multiple Sites
Psychological Sexual Dysfunctions, Sexual Arousal Disorder
NCT00746967
Females
18+
Years
Multiple Sites
A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil
Non-Interventional, Prospective Study Of the Evaluation Of Patients Population With ED, Treated With Sildenafil
In the present study, it is planned to observe a population of 100 ED patients treated previously with udenafil and for whom their physician decided to switch them to sildenafil because of poor udenafil tolerance and/or poor efficacy.
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
- Patients, aged >18 years and having been switched to sildenafil after a previous treatment with udenafil proved ineffective and/or was poorly tolerated. The evaluation of udenafil ineffectivness should be performed after attempt intercourse 2 times a week over the course of four weeks.
Erectile Dysfunction
Drug: sildenafil
tables, 25,50,100 mg, on demand, 1 month
Patients with erectile dysfunction (ED)
100 ED patients in the study that were switched to sildenafil after a previous treatment with udenafil proved ineffective and/or was poorly tolerated
Intervention: Drug: sildenafil
Not Provided


*   Includes publications given by the data provider as well as publications
identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
October 2011
October 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Male patients aged ? 18 years.
  • Clinical diagnosis of erectile dysfunction supported by a total score of less than or equal to 21 according to Sexual Health Inventory-Male (SHI-M).
  • Patients having a sexual partner throughout the study.
  • Patients having been switched to sildenafil after a previous treatment with udenafil proved ineffective and/or was poorly tolerated. The evaluation of udenafil ineffectivness should be performed after attempt intercourse 2 times a week over the course of four weeks.

Exclusion Criteria:

  • The patients for whom sildenafil is contraindicated according to the Local Product Document (LPD). (See appendix D)
  • The patients for whom sexual activity is not indicated.
Sexes Eligible for Study: Male
18 Years to 80 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
 
NCT01108900
A1481271
No
Not Provided
Not Provided
Pfizer
Pfizer
Not Provided
Study Director: Pfizer CT.gov Call Center Pfizer
Pfizer
December 2011

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting thte study website. To get updates and notications about this trail, sign up using the form below.

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]



Call Now